GlaxoSmithKline | Vermögenswerte



Assets Veränderung Datum
AbbVie USD 135.16B 8.26B 2024-12
Alcon AG USD 30.35B 15M 2024-12
Almirall EUR 2.32B 14.19M 2024-06
Amgen USD 91.84B 956M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Fresenius EUR 43.55B 1.18B 2024-12
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Galapagos EUR 4.02B 113.77M 2025-03
Genmab DKK 45.81B 6.15B 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Glaxosmithkline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Merck USD 117.11B 426M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novo Nordisk 397.44B 28.06B 2024-09
Orion EUR 1.7B 72.7M 2025-03
Pfizer USD 213.4B 6.08B 2024-12
Philips EUR 28.98B 498M 2024-12
Recordati EUR 4.2B 2.87M 2024-09
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
Smith & Nephew USD 10.35B 188M 2024-12
UCB EUR 17.35B 1.72B 2024-12



GlaxoSmithKline Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.